A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
NCT00761176
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class
Stopped
Protocol Violations noted for 6 of 8 patients
Conditions
Diabetic Foot Ulcers
Interventions
DEVICE:
The Provant Therapy System
Sponsor
Regenesis Biomedical, Inc.